» Articles » PMID: 22568415

Hepatocellular Adenoma: an Excellent Indication for Laparoscopic Liver Resection

Overview
Journal HPB (Oxford)
Publisher Elsevier
Specialty Gastroenterology
Date 2012 May 10
PMID 22568415
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Laparoscopic resection for benign liver disease has gained wide acceptance in recent years and hepatocellular adenoma (HA) seems to be an appropriate indication. This study aimed to discuss diagnosis and treatment strategies, and to assess the feasibility, safety and outcomes of pure laparoscopic liver resection (LLR) in a large series of patients with HA.

Methods: Of 88 patients who underwent pure LLR, 31 were identified as having HA. Diagnosis was based on radiological evaluation and resections were performed for lesions measuring >5.0 cm.

Results: The sample included 29 female and two male patients. Their mean age was 33.2 years. A total of 27 patients had a single lesion, one patient had two and one had four lesions. The two remaining patients had liver adenomatosis. Mean tumour size was 7.5 cm. Three right hepatectomies, 17 left lateral sectionectomies and 11 wedge resections or segmentectomies were performed. There was no need for blood transfusion or conversion to open surgery. Postoperative complications occurred in two patients. Mean hospital stay was 3.8 days.

Conclusions: Hepatocellular adenoma should be regarded as an excellent indication for pure LLR. Pure LLR is safe and feasible and should be considered the standard of care for the treatment of HA when performed by surgeons with experience in liver and laparoscopic surgery.

Citing Articles

LAPAROSCOPIC LIVER RESECTION FOR BENIGN TUMORS: THE CURRENT POSITION.

Herman P, Fonseca G, Pirola Kruger J, Jeismann V, Coelho F Arq Bras Cir Dig. 2022; 34(4):e1641.

PMID: 35107503 PMC: 8846456. DOI: 10.1590/0102-672020210002e1641.


Indocyanine green fluorescence navigation in laparoscopic hepatectomy: a retrospective single-center study of 120 cases.

Lu H, Gu J, Qian X, Dai X Surg Today. 2020; 51(5):695-702.

PMID: 33128594 PMC: 8055570. DOI: 10.1007/s00595-020-02163-8.


Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons' Perspective.

Herman P, Fonseca G, Pirola Kruger J, Jeismann V, Coelho F J Gastrointest Surg. 2020; 25(6):1494-1502.

PMID: 32666496 DOI: 10.1007/s11605-020-04724-1.


Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imaging.

Lim H, Heng Chiow A, Lee L, Tan S, Goh B, Koh Y Singapore Med J. 2019; 62(4):182-189.

PMID: 31680180 PMC: 8801829. DOI: 10.11622/smedj.2019137.


LIVER RESECTION IN BRAZIL: A NATIONAL SURVEY.

Fonseca G, Jeismann V, Pirola Kruger J, Coelho F, Montagnini A, Herman P Arq Bras Cir Dig. 2018; 31(1):e1355.

PMID: 29947689 PMC: 6049998. DOI: 10.1590/0102-672020180001e1355.


References
1.
Azagra J, Goergen M, Gilbart E, Jacobs D . Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 1996; 10(7):758-61. DOI: 10.1007/BF00193052. View

2.
Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V . Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2010; 60(1):85-9. DOI: 10.1136/gut.2010.222109. View

3.
Saint Marc O, Cogliandolo A, Piquard A, Fama F, Pidoto R . Early experience with laparoscopic major liver resections: a case-comparison study. Surg Laparosc Endosc Percutan Tech. 2008; 18(6):551-5. DOI: 10.1097/SLE.0b013e318180c93b. View

4.
Herman P, Pugliese V, Machado M, Montagnini A, SALEM M, Bacchella T . Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. 2000; 24(3):372-6. DOI: 10.1007/s002689910059. View

5.
Katkhouda N, Mavor E, Gugenheim J, Mouiel J . Laparoscopic management of benign cystic lesions of the liver. J Hepatobiliary Pancreat Surg. 2000; 7(2):212-7. DOI: 10.1007/s005340050178. View